Literature DB >> 17298624

Cause and place of death in patients dying with colorectal cancer.

O M Jones1, S K P John, N Horseman, R J Lawrance, J B J Fozard.   

Abstract

OBJECTIVE: Few studies on colorectal cancer look at the one-third of patients for whom treatment fails and who need a management strategy for death. This paper has examined the mode and place of death in patients with colorectal cancer.
METHOD: This study was a review of 209 deaths, analysed between January 2001 and September 2004 by retrospective review of a prospectively collected database.
RESULTS: A total of 118 patients (group 1) had undergone resection of their primary colorectal cancer, 20 (group 2) had had a defunctioning stoma or bypass surgery and the remaining 71 patients (group 3) had either had no surgery, an open and close laparotomy or had a colonic stent. One hundred and fifty-six (75%) patients died of colorectal cancer with the remainder dying of other causes. The number of admissions to hospital and the number of days spent in hospital from diagnosis to death were greatest in group 1. Overall, only 34 patients (22%) dying from colorectal cancer died at home. Forty (26%) died in hospital and 70 (45%) died in a palliative care unit.
CONCLUSIONS: Patients dying from colorectal cancer who undergo surgical resection of their primary tumour spend more time between diagnosis and death in hospital. They are also more likely to die in hospital than patients treated by surgical palliation or nonsurgically. Patients who are treated palliatively from the outset (group 3) are most likely to die at home. If hospital is accepted as an appropriate place for death from colorectal cancer, then greater provision for this should be made.

Entities:  

Mesh:

Year:  2007        PMID: 17298624     DOI: 10.1111/j.1463-1318.2006.01131.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  5 in total

1.  Colorectal cancer patients: what do they die of?

Authors:  Matias Riihimäki; Hauke Thomsen; Kristina Sundquist; Kari Hemminki
Journal:  Frontline Gastroenterol       Date:  2012-04-27

2.  How do surgeons experience and cope with the death and dying of their patients? A qualitative study in the context of life-limiting illnesses.

Authors:  Sofia C Zambrano; Anna Chur-Hansen; Gregory B Crawford
Journal:  World J Surg       Date:  2013-05       Impact factor: 3.352

3.  Influence of pre-diagnostic cigarette smoking on colorectal cancer survival: overall and by tumour molecular phenotype.

Authors:  Y Zhu; S R Yang; P P Wang; S Savas; T Wish; J Zhao; R Green; M Woods; Z Sun; B Roebothan; J Squires; S Buehler; E Dicks; J Zhao; J R Mclaughlin; P S Parfrey; P T Campbell
Journal:  Br J Cancer       Date:  2014-01-21       Impact factor: 7.640

4.  Abnormal expression of TRIB3 in colorectal cancer: a novel marker for prognosis.

Authors:  N Miyoshi; H Ishii; K Mimori; Y Takatsuno; H Kim; H Hirose; M Sekimoto; Y Doki; M Mori
Journal:  Br J Cancer       Date:  2009-11-17       Impact factor: 7.640

5.  A study of lymph node ratio in stage IV colorectal cancer.

Authors:  Kristoffer Derwinger; Bengt Gustavsson
Journal:  World J Surg Oncol       Date:  2008-12-01       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.